Sign up for conference updates. Enter your email address.

 

Preliminary Schedule

Time

Sessions

8:30 9:00 am Registration
9:00 9:15 am Opening Remarks
9:15 10:30 am Panel 1 - Business of Biotechnology I
10:30 11:45 am Panel 2 - Business of Biotechnology II
11:45 1:00 pm
Luncheon Plenary: You’ve made the leap of faith… How to manage your Career through the challenges posed by industry.
(Lunch will be provided)
1:00 2:00 pm Panel 3 - From Bench to the Bar – Career Pathways in Law
2:00 3:30 pm

Panel 4 - Corporate Perspectives on Workforce

 

Panel Descriptions

    Panel 1 – Business of Biotechnology I
    The life sciences industry is one of the most research-intensive industries in the world. The U.S. biotech industry alone spent $15.6 billion on research and development in 2001. Explore the potential career opportunities in Corporate R & D as industry leaders discuss:
    • The scientific aspects of the biotechnology industry.
    • New and exciting trends in Corporate R & D.
    • Regulatory issues in biotechnology, clinical trial management.
    • Working at the FDA.
       
    Panel 2 – Business of Biotechnology II
    Are you ready to move into industry? Let a panel of experts lead you through the business of biotechnology and explore the opportunities.
    • Gain insight into issues in business development. Economic and business development is challenging at the best of times. Innovative science requires a compatible business model to enable commercialization.
    • Explore important issues and trends influencing venture capital.
    • The challenges of bringing products to market.
    • Behind the scenes efforts of communication professionals in the field. How to make science "sexy". 
       
    Panel 3 – From the Bench to the Bar Presented by Morgan and Finnegan.
    Considering a career in Law? Patents and intellectual property rights are critical to the success of the biotechnology industry. Without patent protection, biotechnology companies cannot afford the risk and expense of bringing a new product to market. Let a panel of experts introduce you to the diverse career pathways in the legal system as they discuss:
    • Legal and regulatory issues affecting the biotechnology industry.
    • The controversy over the role of patents in protecting biotechnology inventions and whether they promote or stifle innovation.
    • Role of Biotechnology ethics.
       
    Panel 4 - Corporate Perspectives on Workforce
    A distinguished panel of industry leaders will discuss the challenges, issues and concerns faced by the life sciences industry as it pertains to workforce needs. Hear their insights on academic training for life scientists, profile of the ideal employee and tips for success.

Distinguished Industry Speakers

Clinton Rubin, PhD. Director, Center for Biotechnology, Professor and Chair, Department of Biomedical
           Engineering, Stony Brook University
Ellis Rubinstein, CEO, New York Academy of Sciences
Zoltan Sarnyai, MD, PhD. Vice President, External Scientific Affairs, PsychoGenics, Inc.
Chris Szustkiewicz, Sr. Vice President , Corporate Development, Target Health, Inc.
Christine Boisclair, Director, Regulatory Affairs. OSI Pharmaceuticals, Inc.
Janine Schwedes, MBA. Manager, Scientific Affairs, OSI Pharmaceuticals, Inc.
Rob Shorr, PhD. DIC. Director, Business Development, Center for Biotechnology.
Jason Alter, PhD. Marketing Manager, IBM Life Sciences.
Cynthia A. Isaac, PhD. Account Supervisor, Noonan Russo Presence
Kenneth H. Sonnenfeld, PhD, JD. Partner, Morgan & Finnegan L.L.P.
Charles Ryan, PhD, JD. Chief Operating Officer and Co-Founder, Lab 21, Inc.
Richard Bork, PhD, JD. Novo Nordisk Pharmaceuticals, Inc.
Tim Cooke, PhD, MBA. CEO, Mojave Therapeutics
Bob Larson, PhD. Associate Director, BioPharmaceuticals, Pall Corporation
Elliott Gruskin, PhD. Vice President of R&D, Acorda Therapeutics
Sandra Kim, Ph.D. Sr. Licensing Assoc., Office of Tech. Licensing & Industry Relations, Stony Brook University

 

 

Center for Biotechnology
Center for Biotechnology
Center for Biotechnology